Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-063645

Chairman & CEO bought 1,200 shares at an average $16.73 ($20,070)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-19 Purchase : show line 1 in the form +200 $18.95 $3,790 2,961,614 D
2022-05-20 Purchase : show line 2 in the form +1,000 $16.28 $16,280 2,962,614 D
Open-market purchases · 1,200 sh · avg $16.73 · $20,070
Loading xslF345X03/tm2216562-2_4seq1.xml…